Cargando…
C1 Esterase Inhibition: Targeting Multiple Systems in COVID-19
Autores principales: | Adesanya, T. M. Ayodele, Campbell, Courtney M., Cheng, Lijun, Ogbogu, Princess U., Kahwash, Rami |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817248/ https://www.ncbi.nlm.nih.gov/pubmed/33474624 http://dx.doi.org/10.1007/s10875-021-00972-1 |
Ejemplares similares
-
Role of hemagglutinin esterase protein in neurological manifestation of COVID-19
por: Zandi, Milad, et al.
Publicado: (2021) -
Alpha defensin, leukocyte esterase, C-reactive protein, and leukocyte
count in synovial fluid for pre-operative diagnosis of periprosthetic
infection
por: De Vecchi, Elena, et al.
Publicado: (2018) -
Hereditary angioedema C1-esterase inhibitor replacement therapy and coexisting autoimmune disorders: findings from a claims database
por: Farkas, Henriette, et al.
Publicado: (2020) -
Response to the letter, entitled “Role of hemagglutinin esterase protein in neurological manifestation of COVID-19”
por: Deane, Rashid
Publicado: (2021) -
Hemagglutinin-esterase cannot be considered as a candidate for designing drug against COVID-19
por: Zandi, Milad, et al.
Publicado: (2021)